PDB20 BIPHASIC INSULIN ASPART 30 VERSUS ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE-2 DIABETES: LONG-TERM PROJECTION OF CLINICAL AND COST OUTCOMES IN SWEDEN

Value in Health ◽

10.1016/s1098-3015(10)67639-5 ◽

2005 ◽

Vol 8 (6) ◽

pp. A160

Author(s):

AJ Palmer ◽

M Lammert ◽

WJ Valentine ◽

JA Ray ◽

AS Brandt ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Hypoglycemic Agents ◽

Oral Hypoglycemic Agents ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Download Full-text

PDB7 LONG TERM COST EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30/70 VERSUS INSULIN GLARGINE IN INSULIN NAÏVE PATIENTS WITH TYPE-2 DIABETES POORLY CONTROLLED ON ORAL HYPOGLYCEMIC AGENTS IN DANISH, DUTCH, FINNISH, FRENCH, GERMAN, NORWEGIAN, SPANISH, SWEDISH AND UK SETTINGS

Value in Health ◽

10.1016/s1098-3015(10)65950-5 ◽

2004 ◽

Vol 7 (6) ◽

pp. 736-737 ◽

Author(s):

M Lammert ◽

AJ Palmer ◽

S Roze ◽

ME Minshall ◽

WJ Valentine ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Aspart ◽

Hypoglycemic Agents ◽

Oral Hypoglycemic Agents ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia

Journal of Medical Economics ◽

10.3111/13696990802589122 ◽

2008 ◽

Vol 11 (4) ◽

pp. 651-670 ◽

Author(s):

Mohammed Ali ◽

Jeremy White ◽

Chen-Hui Lee ◽

James L Palmer ◽

Jayne Smith-Palmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Saudi Arabia ◽

Insulin Aspart ◽

Long Term Outcomes ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

Letter to the Editor: Comments on: Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 vs insulin glargine in insulin naïve type 2 diabetes patients: cost effectiveness analysis in a UK setting

Current Medical Research and Opinion ◽

10.1185/030079906x104759 ◽

2006 ◽

Author(s):

Craig J. Currie ◽

Phil McEwan ◽

Chris Poole ◽

William J. Valentine ◽

Andrew J. Palmer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30 ◽

Download Full-text

Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes

Value in Health ◽

10.1016/j.jval.2013.03.821 ◽

2013 ◽

Vol 16 (3) ◽

pp. A164

Author(s):

P.D. Home ◽

P. Soewondo ◽

Z. Hussein ◽

A.A. Shafie ◽

K. AlRaddady ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Short And Long Term

Download Full-text

PDB4 LONG-TERM OUTCOMES OF SWITCHING PATIENTS WITH TYPE 2 DIABETES FROM BIPHASIC INSULIN TO BIPHASIC INSULIN ASPART 30/70: AN IMPROVE STUDY SUBGROUP ANALYSIS

Value in Health ◽

10.1016/s1098-3015(10)74982-2 ◽

2009 ◽

Vol 12 (7) ◽

pp. A402

Author(s):

R Ligthelm ◽

TE Christensen ◽

TL Thomsen ◽

W Yang

Keyword(s):

Type 2 Diabetes ◽

Subgroup Analysis ◽

Insulin Aspart ◽

Long Term Outcomes ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2014.08.024 ◽

2014 ◽

Vol 106 (2) ◽

pp. 319-327 ◽

Author(s):

Asrul Akmal Shafie ◽

Vishal Gupta ◽

Ranya Baabbad ◽

Eva Hammerby ◽

Philip Home

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Short And Long Term

Download Full-text

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

Clinical Therapeutics ◽

10.1016/s0149-2918(03)90095-6 ◽

2003 ◽

Vol 25 (12) ◽

pp. 3109-3123 ◽

Author(s):

Itamar Raz ◽

Ulrik Mouritzen ◽

Julius Vaz ◽

Tommy Hershkovitz ◽

Julio Wainstein ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text

PDB24 COST EFFECTIVENESS ANALYSIS OF SWITCHING PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES TO BIPHASIC INSULIN ASPART 30 FROM BIPHASIC HUMAN INSULIN 30 IN THE CZECH SETTING

Value in Health ◽

10.1016/s1098-3015(10)75002-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A405-A406

Author(s):

E Suchankova ◽

T Doležal ◽

Z Pisarikova ◽

K Rychna ◽

D Bartaskova

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Human Insulin ◽

Insulin Aspart ◽

Cost Effectiveness Analysis ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Effectiveness Analysis ◽

Biphasic Insulin Aspart 30

Download Full-text

Biphasic Insulin Aspart 30 Three Times Daily Is More Effective Than a Twice-Daily Regimen, Without Increasing Hypoglycemia, in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Drugs

Diabetes Care ◽

10.2337/dc07-1992 ◽

2008 ◽

Vol 31 (5) ◽

pp. 852-856 ◽

Author(s):

W. Yang ◽

Q. Ji ◽

D. Zhu ◽

J. Yang ◽

L. Chen ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Aspart ◽

Daily Regimen ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Oral Antidiabetes Drugs ◽

Chinese Subjects

Download Full-text

PDB5 GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30

Value in Health ◽

10.1016/s1098-3015(10)72252-x ◽

2010 ◽

Vol 13 (3) ◽

pp. A55 ◽

Author(s):

W Fakhoury ◽

H Richter ◽

T Christensen ◽

TL Thomsen ◽

D Irwin ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Human Insulin ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30

Download Full-text